{"id":"https://openalex.org/W6981338202","doi":null,"title":"Effektiviteten av tirzepatid j\u00e4mf\u00f6rt med andra konventionella l\u00e4kemedelsbehandlingar mot typ-2 diabetes","display_name":"Effektiviteten av tirzepatid j\u00e4mf\u00f6rt med andra konventionella l\u00e4kemedelsbehandlingar mot typ-2 diabetes","alternate_titles":[],"publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W6981338202"},"language":"sv","primary_location":{"id":"pmh:oai:DiVA.org:umu-209726","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-209726","pdf_url":"https://umu.diva-portal.org/smash/get/diva2:1766880/FULLTEXT01","source":{"id":"https://openalex.org/S4306400361","display_name":"DiVA at Ume\u00e5 University (Ume\u00e5 University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I90267481","host_organization_name":"Ume\u00e5 University","host_organization_lineage":["https://openalex.org/I90267481"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/bachelorThesis"},"parent_works":[],"lineage":["https://openalex.org/W6981338202"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://umu.diva-portal.org/smash/get/diva2:1766880/FULLTEXT01","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Al-Sammak, Ula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I90267481","display_name":"Ume\u00e5 University","ror":"https://ror.org/05kb8h459","country_code":"SE","type":"education","lineage":["https://openalex.org/I90267481"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Al-Sammak, Ula","raw_affiliation_strings":["Receptarieprogrammet, UME\u00c5 UNIVERSITET"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Receptarieprogrammet, UME\u00c5 UNIVERSITET","institution_ids":["https://openalex.org/I90267481"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I90267481"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.8669999837875366},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8740000128746033},{"id":"https://openalex.org/keywords/gip-receptor-agonist","display_name":"GIP receptor agonist","score":0.9480000138282776},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.7770000100135803},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.9419999718666077},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6930000185966492},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.6769999861717224},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.460999995470047},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.3840000033378601},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.37400001287460327},{"id":"https://openalex.org/keywords/glp-1-receptor-antagonists","display_name":"GLP-1 receptor antagonists","score":0.6050000190734863},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6330000162124634},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3799000084400177},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2630999982357025},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23899999260902405},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.20270000398159027},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.20190000534057617},{"id":"https://openalex.org/C545542383","wikidata":"https://www.wikidata.org/wiki/Q2751242","display_name":"Medical emergency","level":1,"score":0.18809999525547028},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.17990000545978546},{"id":"https://openalex.org/C2776401178","wikidata":"https://www.wikidata.org/wiki/Q12050496","display_name":"Feature (linguistics)","level":2,"score":0.179299995303154},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1688999980688095}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:DiVA.org:umu-209726","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-209726","pdf_url":"https://umu.diva-portal.org/smash/get/diva2:1766880/FULLTEXT01","source":{"id":"https://openalex.org/S4306400361","display_name":"DiVA at Ume\u00e5 University (Ume\u00e5 University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I90267481","host_organization_name":"Ume\u00e5 University","host_organization_lineage":["https://openalex.org/I90267481"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/bachelorThesis"}],"best_oa_location":{"id":"pmh:oai:DiVA.org:umu-209726","doi":null,"is_oa":true,"landing_page_url":"http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-209726","pdf_url":"https://umu.diva-portal.org/smash/get/diva2:1766880/FULLTEXT01","source":{"id":"https://openalex.org/S4306400361","display_name":"DiVA at Ume\u00e5 University (Ume\u00e5 University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I90267481","host_organization_name":"Ume\u00e5 University","host_organization_lineage":["https://openalex.org/I90267481"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/bachelorThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W6981338202.pdf","grobid_xml":"https://content.openalex.org/works/W6981338202.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1885494502","https://openalex.org/W1973286355","https://openalex.org/W2009181620","https://openalex.org/W2042850859","https://openalex.org/W2123946565","https://openalex.org/W2335829884","https://openalex.org/W2561206249","https://openalex.org/W2895666357","https://openalex.org/W2971340278","https://openalex.org/W3004172664","https://openalex.org/W3019636814","https://openalex.org/W3044587011","https://openalex.org/W3177122952","https://openalex.org/W3177393241","https://openalex.org/W3184250385","https://openalex.org/W3206180121","https://openalex.org/W4210940103","https://openalex.org/W4224257527","https://openalex.org/W4281388633","https://openalex.org/W4283790832","https://openalex.org/W4285087957","https://openalex.org/W4288740467","https://openalex.org/W4289868569","https://openalex.org/W4308040595","https://openalex.org/W4311206282","https://openalex.org/W4313529365"],"related_works":["https://openalex.org/W4403523626","https://openalex.org/W6887792719","https://openalex.org/W4200216881","https://openalex.org/W4411194779","https://openalex.org/W4286222566","https://openalex.org/W4312214397","https://openalex.org/W3211017522","https://openalex.org/W4319224981","https://openalex.org/W4282945047","https://openalex.org/W4410019825"],"abstract_inverted_index":{"InledningIdag":[0],"klassificeras":[1],"diabetes":[2,25,45,371,403],"typ-2":[3,8,26,372,404],"som":[4,41,52,68,85,124,189,255,261,277,310,331,356,397,433],"en":[5,28,36,117,126,182,288,326,391,412,436],"kronisk":[6],"sjukdom.Diabetes":[7],"k\u00e4nnetecknas":[9],"av":[10,17,31,37,102,329],"h\u00f6g":[11,413,422],"glukosniv\u00e5":[12],"i":[13,54,176,191,235,248,270,348,393,438],"blod":[14],"p\u00e5":[15,155,275,299],"grund":[16],"insulinresistens.\u03b2-cellerna":[18],"\u00e4r":[19,27,35,89,120,125,141,273,378],"ansvariga":[20],"f\u00f6r":[21,179,368,424],"insulinuts\u00f6ndring,":[22],"men":[23,77],"vid":[24,307],"stor":[29,100],"andel":[30,101],"\u03b2-cellernas":[32],"funktion":[33],"f\u00f6rst\u00f6rd.Fetma":[34],"de":[38,166,200,245],"viktigaste":[39],"orsakerna":[40],"kan":[42,63,69,150,352],"leda":[43,64],"till":[44,65,79,93,116,208,268,415],"typ-2.Inkretinhormonerna":[46],"GLP-1":[47,134,361,386,417],"och":[48,72,129,135,148,165,218,233,251,265,281,294,297,316,337,346,350,387,395,418],"GIP":[49,388,419],"stimulerar":[50],"\u03b2-celler":[51],"finns":[53,86],"pankreas":[55],"inom":[56],"s.k.Lagerhanska":[57],"\u00f6ar,":[58],"d\u00e4r":[59],"det":[60,96,107,121,185,319,325],"produceras":[61],"insulin.Diabetes":[62],"kardiovaskul\u00e4ra":[66],"sjukdomar":[67],"\u00f6ka":[70],"v\u00e5rdbehov":[71],"kosta":[73],"samh\u00e4llet":[74],"mycket":[75],"pengar,":[76],"\u00e4ven":[78],"tidigt":[80],"d\u00f6d.M\u00e5let":[81],"med":[82,138,146,170,230,257,334,344,354,406],"farmakologiska":[83],"behandlingar":[84],"nup\u00e5":[87],"marknaden":[88],"att":[90,142,153,161,180,198,223,369],"s\u00e4nka":[91,162],"HbA1c":[92,109,249,349,394],"normala":[94,108],"niv\u00e5er,":[95],"vill":[97],"s\u00e4ga":[98],"<7%.En":[99],"diabetiker":[103],"kunde":[104],"inte":[105],"uppn\u00e5":[106],"v\u00e4rde":[110],"vilket":[111,284,426],"framkallade":[112],"ett":[113],"stort":[114],"behov":[115],"ny":[118,321],"behandling.Tirzepatid":[119],"f\u00f6rsta":[122],"l\u00e4kemedel":[123,247],"dubbel":[127],"agonist":[128],"sl\u00e5r":[130,382],"mot":[131,383],"tv\u00e5":[132,384],"receptorer,":[133,385],"GIP.":[136],"SyfteSyftet":[137],"detta":[139,177],"examensarbete":[140,178],"j\u00e4mf\u00f6ra":[143],"tirzepatid":[144,224,258,333,379],"effekt":[145],"semaglutid":[147,345],"dulaglutid.Detta":[149],"uppn\u00e5s":[151],"genom":[152],"titta":[154],"olika":[156,236,300],"parametrar":[157],"s\u00e5som":[158],"tirzepatids":[159],"f\u00f6rm\u00e5ga":[160],"HbA1c,":[163],"kroppsvikt":[164,396],"vanligaste":[167,253],"biverkningar":[168],"associerade":[169],"typ":[171],"2":[172,293],"diabetes.":[173],"MetodPubmed":[174],"anv\u00e4ndes":[175],"g\u00f6ra":[181],"litteraturstudie.Totalt":[183],"var":[184,225,243,259,266,287],"\u00e5tta":[186],"original":[187],"artiklar":[188,203],"inkluderades":[190],"arbetet.Alla":[192],"studier":[193,210,296,330],"har":[194,421],"samma":[195],"inklusions-och":[196],"exklusionskriterier.F\u00f6r":[197],"hitta":[199],"mest":[201,374],"relevanta":[202],"hade":[204,278,398,411],"vissa":[205],"begr\u00e4nsningar":[206],"anv\u00e4nts,":[207],"exempel":[209],"ska":[211],"vara":[212],"5":[213],"\u00e5r":[214],"gamla":[215],"eller":[216],"mindre":[217],"randomiserad":[219],"dubbelblind.":[220],"ResultatResultatet":[221],"visade":[222,339,390],"betydligt":[226],"mer":[227],"effektivt":[228],"j\u00e4mf\u00f6rt":[229,343],"semaglutid,":[231,335],"Dulaglutid":[232],"placebo.Tirzepatid":[234,338],"doser":[237],"(1,5,":[238],"10,":[239],"12,":[240],"15":[241],"mg)":[242],"\u00f6verl\u00e4gsen":[244],"andra":[246,360],"minskning":[250,392],"viktreducering.De":[252],"biverkning":[254],"f\u00f6rekommer":[256],"gastrointestinala":[260],"minskade":[262],"\u00f6ver":[263,302],"tiden":[264],"milda":[267],"sv\u00e5ra":[269],"sv\u00e5righetsgrad.":[271],"DiskussionExamensarbetet":[272],"baserat":[274],"litteraturstudier":[276],"b\u00e5de":[279],"positiva":[280],"negativa":[282],"aspekter":[283],"p\u00e5verkat":[285],"resultatet.Studierna":[286],"blandning":[289],"mellan":[290],"fas":[291],"1,":[292],"3":[295],"utf\u00f6rdes":[298],"platser":[301],"hela":[303],"v\u00e4rlden.Litteraturstudier":[304],"passar":[305],"bra":[306],"vetenskapliga":[308],"unders\u00f6kningar":[309],"m\u00e5ste":[311],"utf\u00f6ras":[312],"under":[313],"kort":[314],"tid":[315],"dessutom":[317],"n\u00e4r":[318],"g\u00e4ller":[320],"l\u00e4kemedelsbehandling.":[322],"D\u00e4remot":[323],"fanns":[324],"begr\u00e4nsat":[327],"utbud":[328],"j\u00e4mf\u00f6r":[332],"dulaglutid":[336,347],"signifikant":[340],"dosberoende":[341],"f\u00f6rb\u00e4ttring":[342],"viktminskning.Detta":[351],"f\u00f6rknippas":[353],"tirzepatidstrukturer":[355],"skiljer":[357],"sig":[358],"fr\u00e5n":[359],"agonister.":[362],"SlutsatsInkretin":[363],"analoger":[364],"(GLP-1":[365],"antagonister)":[366],"anv\u00e4nds":[367],"f\u00f6rb\u00e4ttra":[370],"behandling.Den":[373],"lovande":[375],"inkretin":[376],"analogen":[377],"eftersom":[380],"den":[381,432],"agonist.tirzepatid":[389],"aldrig":[399],"tidigare":[400],"visats":[401],"bland":[402],"behandlingar.Tirzepatid":[405],"sin":[407],"unika":[408],"molekyl\u00e4r":[409],"struktur":[410],"bindningsaffinitet":[414],"b\u00e5da":[416],"receptorer.Tirzepatid":[420],"affinitet":[423],"albumin,":[425],"m\u00f6jligg\u00f6r":[427],"l\u00e5ng":[428],"halveringstid":[429],"d\u00e4rf\u00f6r":[430],"ges":[431],"subkutan":[434],"injektion":[435],"g\u00e5ng":[437],"veckan.":[439]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6981338202","counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2025-10-10T00:00:00"}
